Entry Rationale
Since the current closing price of $15.46 is lower than the reported support level of $16.91, we consider a purchase in anticipation of a rebound within the defensive zone.
RBC Capital upgrades Arxis stock rating on M&A activity, pricing
RBC Capital upgraded the stock, reflecting positive outlooks on ARIS's M&A activity and pricing.
Since the current closing price of $15.46 is lower than the reported support level of $16.91, we consider a purchase in anticipation of a rebound within the defensive zone.
If the stock price reaches the resistance level of $20.81, sell at the target price to take profits, and if the stock price falls below the support level of $16.91, sell at the stop-loss price.
RSI (14) at 34.7 (oversold), moving averages in a non-bullish alignment, trading volume up 1.52x compared to the 20-day average, and a -12.7% rate of change over the past 7 days indicate a downward trend.
Compared to the predicted return of 2.5%, an actual loss of -10.8% occurred. While the upside resistance target and downside support level were set accurately, the entry timing was inappropriate as the oversold signal and downward trend were not sufficiently reflected.
For the next trade, greater weight will be placed on downward signals such as the RSI oversold condition and the 7-day rate of change, and entry conditions will be tightened to allow execution only when the current price is above the support line. In addition, sudden surges in trading volume and changes in disclosure contents will be monitored in real time to cut off risks early.